heartburn

Showing 1 - 25 of 59

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Heartburn, Dyspepsia Trial in Basel (App-based treatment support)

Recruiting
  • Heartburn
  • Dyspepsia
  • App-based treatment support
  • Basel, Basel-Stadt, Switzerland
    TopPharm Apotheke am Spalebärg
Oct 18, 2023

Gastroesophageal Reflux, Heartburn Trial in Amsterdam (LEFT smartwatch app)

Recruiting
  • Gastroesophageal Reflux
  • Heartburn
  • LEFT smartwatch app
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC
Oct 3, 2023

Gastroesophageal Reflux, Regurgitation, Heartburn Trial in Jacksonville (Breath Testing)

Not yet recruiting
  • Gastroesophageal Reflux
  • +2 more
  • Breath Testing
  • Jacksonville, Florida
    Mayo Clinic Florida
Jul 27, 2023

Prevalence of Fuctional Heartburn in Patients With IBS .

Not yet recruiting
  • Heartburn
    • (no location specified)
    Jun 5, 2023

    Non-Erosive Gastro-Esophageal Reflux Disease, Heartburn Trial in United States (Vonoprazan, Placebo)

    Completed
    • Non-Erosive Gastro-Esophageal Reflux Disease
    • Heartburn
    • Anniston, Alabama
    • +62 more
    Dec 8, 2022

    Heartburn, Dyspepsia, Reflux Trial in Leuven (de-prescription of PPI via intermittent scheme, de-prescription of PPI via

    Not yet recruiting
    • Heartburn
    • +2 more
    • de-prescription of PPI via intermittent scheme
    • +2 more
    • Leuven, Vlaams Brabant, Belgium
      Jan Tack
    Nov 16, 2022

    Heartburn Trial in Cleveland (Optimal Dosing of Omeprazole)

    Completed
    • Heartburn
    • Optimal Dosing of Omeprazole
    • Cleveland, Ohio
      MetroHealth Medical System
    Oct 23, 2022

    Non-Erosive Gastro-Esophageal Reflux Disease, Heartburn Trial in United States (Vonoprazan, Placebo)

    Recruiting
    • Non-Erosive Gastro-Esophageal Reflux Disease
    • Heartburn
    • Athens, Alabama
    • +93 more
    Aug 16, 2022

    Heartburn Trial in Manassas (Panosyl-isomaltooligosaccharides (PIMO) 1g (1.4 ml), Placebo 1.4 ml)

    Recruiting
    • Heartburn
    • Panosyl-isomaltooligosaccharides (PIMO) 1g (1.4 ml)
    • Placebo 1.4 ml
    • Manassas, Virginia
      Microbiome Health Sciences
    May 3, 2022

    Caffeine Dependence, Anxiety, Sleep Disturbance Trial in Baltimore (Caffeine Reduction Manual)

    Recruiting
    • Caffeine Dependence
    • +15 more
    • Caffeine Reduction Manual
    • Baltimore, Maryland
      Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Med
    Mar 15, 2022

    Acne, Bites, Burns Trial in Madrid (Minor ailment service)

    Recruiting
    • Acne
    • +30 more
    • Minor ailment service
    • Madrid, Spain
      Spanish Society of Community Pharmacy
    Feb 18, 2022

    Gastroesophageal; Reflux With Esophagitis, Gastroesophageal Reflux, GERD Trial in Moscow (Dietary assessment)

    Recruiting
    • Gastroesophageal; Reflux With Esophagitis
    • +5 more
    • Dietary assessment
    • Moscow, Russian Federation
      Gastroenterology and Hepatology, FRC Nutrition and Biotechnology
    Feb 2, 2022

    Risk Factors After Therapeutic Biliary Interventions

    Completed
    • Dyspepsia
    • +2 more
    • upper GIT endescopy
    • Zagazig, Sharkia, Egypt
      Zagazig University Hospitals
    Nov 24, 2021

    Indigestion, Heartburn Trial in New York (HLNatural, Inc. Upset Stomach Relief)

    Completed
    • Indigestion
    • Heartburn
    • HLNatural, Inc. Upset Stomach Relief
    • New York, New York
      HLNatural, Inc.
    Nov 5, 2021

    Dyspepsia, Heartburn Trial in Spain (Mipolixin®, Poliprotect®)

    Completed
    • Dyspepsia
    • Heartburn
    • Mipolixin®
    • Poliprotect®
    • Albuñol, Spain
    • +10 more
    May 25, 2021

    Heartburn, Acid Regurgitation Trial in Gainesville (Gastro-AD®, Placebo)

    Completed
    • Heartburn
    • Acid Regurgitation
    • Gastro-AD®
    • Placebo
    • Gainesville, Florida
      Food Science and Human Nutrition Department
    Jun 5, 2020

    Heartburn, Gastroesophageal Reflux Disease Trial in China (Dexlansoprazole, Placebo)

    Completed
    • Heartburn
    • Gastroesophageal Reflux Disease
    • Beijing, Beijing, China
    • +24 more
    Jul 3, 2019

    Dyspepsia, Hematemesis, Abdominal Pain Trial in Helsinki (Anesthetics, Local, Sodium Chloride 0.9%)

    Unknown status
    • Dyspepsia
    • +3 more
    • Anesthetics, Local
    • Sodium Chloride 0.9%
    • Helsinki, Uusimaa, Finland
      Department of Anesthesiology and Intensive care medicine, Diviso
    May 3, 2019

    Heartburn Trial in Oklahoma City (Esomeprazole 20 mg, Placebo)

    Completed
    • Heartburn
    • Esomeprazole 20 mg
    • Placebo
    • Oklahoma City, Oklahoma
    • +1 more
    Mar 8, 2017

    Gastroesophageal Reflux Disease (GERD), Heartburn, Dyspepsia Trial in Boston (Supplement, Placebo, Expanded Interview)

    Completed
    • Gastroesophageal Reflux Disease (GERD)
    • +2 more
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Feb 24, 2017

    Heartburn Trial in Oklahoma City (Itopride, Placebo)

    Completed
    • Heartburn
    • Oklahoma City, Oklahoma
      The Oklahoma Foundation for Digestive Research
    Feb 7, 2017

    Anemia, Constipation, Diarrhea Trial in London (ferrous sulfate, Placebo)

    Completed
    • Anemia
    • +5 more
    • ferrous sulfate
    • Placebo
    • London, United Kingdom
      King's College London
    Feb 3, 2017

    Heartburn, Gastroesophageal Reflux Disease Trial in Chapel Hill (Dexlansoprazole)

    Completed
    • Heartburn
    • Gastroesophageal Reflux Disease
    • Chapel Hill, North Carolina
      University of North Carolina at Chapel Hill
    Dec 16, 2016

    Gastroesophageal Reflux Disease, Heartburn, Regurgitation Trial in Indianapolis (Mucosectomy, Rubber Band Ligation)

    Terminated
    • Gastroesophageal Reflux Disease
    • +3 more
    • Mucosectomy
    • Rubber Band Ligation
    • Indianapolis, Indiana
      Indiana University Hospital
    Jun 17, 2015